NCT00834496: Switching From One Type of Anti-rejection Drug (Tacrolimus or Cyclosporine) to Another (Sirolimus) Approximately 90-180 Days After Liver Transplantation |
|
|
| Withdrawn | N/A | 0 | US | Liver biopsy | Thomas Jefferson University, Wyeth is now a wholly owned subsidiary of Pfizer | Side Effects of Calcineurin Inhibitors, Renal Toxicity, Hepatic Fibrosis on Biopsy, Neurotoxicity, Post Transplant Diabetes | 01/10 | 01/10 | | |
